Trial intelligence / Profile preview

Acetylsalicylic Acid in ICU Patients

NCT02285153Phase 3Terminated

Sponsor
Medical University of Vienna
Start
Nov 2011
Primary completion
Sep 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of aspirin in critical illness, sponsored by Medical University of Vienna. Started Nov 2011; status: terminated.

02

Drugs

aspirin
03

Conditions

critical illness

Beyond the preview

Go deeper on NCT02285153.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02285153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call